Navigation Links
Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2015 Results
Date:10/22/2015

SAN DIEGO, Oct. 22, 2015 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its third quarter 2015 financial results after the Nasdaq market closes on Thursday, October 29, 2015.  Neurocrine will then host a live conference call and webcast to discuss its financial results and provide a Company update Thursday afternoon, October 29, 2015 at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).

Participants can access the live conference call by dialing 866-952-1907 (US) or 785-424-1826 (International) using the conference ID: NBIX. The call can also be accessed via the webcast through the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600.  A replay of the conference call will be available approximately one hour after the conclusion of the call by dialing 800-839-5127 (US) or 402-220-2692 (International) using the conference ID: NBIX. The call will be archived for one month.

Neurocrine Biosciences, Inc. discovers and develops innovative and life-changing pharmaceuticals, in diseases with high unmet medical needs, through its novel R&D platform, focused on neurological and endocrine based diseases and disorders. The Company's two lead late-stage clinical programs are elagolix, a gonadotropin-releasing hormone antagonist for women's health that is partnered with AbbVie Inc., and NBI-98854, a vesicular monoamine transporter 2 inhibitor for the treatment of movement disorders. Neurocrine intends to maintain certain commercial rights to its VMAT2 inhibitor for evolution into a fully-integrated pharmaceutical company. 

Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.

 


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. Neurocrine Announces Initiation of Phase II Clinical Study of VMAT2 Inhibitor NBI-98854 in Adults with Tourette Syndrome
2. Neurocrine Announces Positive Results from Phase III Kinect 3 Study of NBI-98854 in Tardive Dyskinesia
3. Neurocrine Biosciences Announces the Appointment of George J. Morrow to its Board of Directors
4. Neurocrine Biosciences to Present at the Morgan Stanley Global Healthcare Conference
5. Neurocrine Biosciences to Present at the Baird 2015 Healthcare Conference
6. Neurocrine Announces Completion of Enrollment into Kinect 3 Tardive Dyskinesia Study
7. Neurocrine Biosciences Reports Second Quarter 2015 Results
8. Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2015 Results
9. Neurocrine Biosciences Provides Update on NBI-77860 Program for Congenital Adrenal Hyperplasia
10. Neurocrine Biosciences to Host Analyst and Investor Day in New York City on May 21, 2015
11. Neurocrine Biosciences to Present at the Bank of America Merrill Lynch 2015 Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2019)... ... December 06, 2019 , ... Plant Life Company ... Supply LLC (a division of Horticultural Holdings LLC) to recommend Plant Life Company’s ... , FFGS is a team of disciplined and energetic plant lovers formally educated ...
(Date:12/4/2019)... ... ... The Harm Reduction Institute (HRI) as a part of the American Addiction ... and non-profit Intensive outpatient after care (IOP) , has officially launched its ... amongst members of the own community in Orange County, CA. , They hope ...
(Date:12/2/2019)... ... December 02, 2019 , ... A ... for Michael, an intensive mental health facility, announced it has named Tim Ryan ... business development and national advocacy efforts. , "We are proud to announce that ...
Breaking Medicine Technology:
(Date:12/8/2019)... ... December 08, 2019 , ... Intelligent.com, a trusted ... 52 Best Homeland Security Degree Programs for 2020. The comprehensive research guide is ... Each program is evaluated based on curriculum quality, graduation rate, reputation, and post-graduate ...
(Date:12/6/2019)... ... December 06, 2019 , ... Allegheny Health Network (AHN) has named ... joined AHN from WVU Medicine in May 2018, previously served as AHN’s Vice Chair ... interim chair since October and is also part of the pathology faculty at Drexel ...
(Date:12/6/2019)... ... 06, 2019 , ... Dr. Scott Howell, a 2019 graduate of Trident University ... health benefits of coconut oil in the 7 November 2019 edition of Progress ... Profile: A Structured Literature Review,” led by Dr. Hector O. Santos, examines the effect ...
(Date:12/5/2019)... ... December 05, 2019 , ... It’s been an ... products that help people embrace, achieve, and maintain a healthy lifestyle to giving ... committed to our mission of impacting world health, so it’s gratifying to look ...
(Date:12/4/2019)... ... December 04, 2019 , ... Healthcare Real ... the only national awards dedicated to recognizing excellence in the areas of healthcare ... presented in nine different categories during the GlobeSt Healthcare Conference today in Scottsdale, ...
Breaking Medicine News(10 mins):